Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Last Updated: May 26, 2022

Hikma Farmaceutica Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for HIKMA FARMACEUTICA, and what generic and branded alternatives to HIKMA FARMACEUTICA drugs are available?

HIKMA FARMACEUTICA has forty approved drugs.

Summary for Hikma Farmaceutica

US Patents:	0
Tradenames:	36
Ingredients:	30
NDAs:	40

Drugs and US Patents for Hikma Farmaceutica

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign up for a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hikma Farmaceutica	FLUMAZENIL	flumazenil	INJECTABLE;INJECTION	078527-001	Mar 23, 2009	AP	RX	No	No		See Plans and Pricing				See Plans and Pricing
Hikma Farmaceutica	CLONIDINE HYDROCHLORIDE	clonidine hydrochloride	INJECTABLE;INJECTION	200300-001	Jan 26, 2011	AP	RX	No	No		See Plans and Pricing				See Plans and Pricing
Hikma Farmaceutica	FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	fluconazole	INJECTABLE;INJECTION	078698-002	Jan 30, 2012	AP	RX	No	No		See Plans and Pricing				See Plans and Pricing
Hikma Farmaceutica	BUTORPHANOL TARTRATE	butorphanol tartrate	INJECTABLE;INJECTION	078247-001	Apr 29, 2009		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Hikma Farmaceutica	ENALAPRILAT	enalaprilat	INJECTABLE;INJECTION	078687-001	Dec 23, 2008	AP	RX	No	Yes		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Boehringer Ingelheim

Medtronic

McKesson

Harvard Business School

Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.